期刊文献+

导向性人干扰素α2a工程菌的高密度发酵 被引量:10

High cell density fermentation of engneering E. coli expressing tumor targeted interferon-α2a
下载PDF
导出
摘要 目的 :优化大肠杆菌表达导向性人干扰素α2a的中试发酵工艺 ,以获得工程菌的高密度发酵和目的蛋白的高表达 .方法 :采用发酵罐发酵 ,对影响工程菌生长和目的蛋白表达的条件 ,如pH值、活化时间、诱导时间、溶氧范围及补料流加方式等进行优化 .结果 :根据优化条件 ,连续三批重复发酵10L工程菌 ,最终菌体密度均达A60 0nm2 5~ 30 ,菌体获得量均可达湿重 5 0g/L以上 ,目的蛋白表达量均为 3.2× 10 9U/L以上 .结论 :此发酵工艺具有周期短、产量高以及重复性稳定性好的特点 ,为下游纯化和进一步大规模生产奠定基础 . AIM: To optimize the pilot-scale fermentation procedure of E.coli producing tumor targeted human IFN-α2a and to obtain high cell density and high level expression of the aim protein. METHODS: The effects of the rang of pH, dissolved oxygen, culture time, induction time and the manner of feeding were analyzed with 10 L of fermentation tank. RESULTS: Under the established conditions, we performed a three-time repeated fermentation. The final cell density was A 600 nm 25-30 and more than 50 g of wet bacteria per liter could be obtained. The expression level of recombinant protein was higher than 3.2×10 9 U/L. CONCLUSION: The results show that the established fermentation procedure is stable, of short cycle and with high expression, which lays the basis for further purification and large-scale production of IFN-α2a-NGR.
出处 《第四军医大学学报》 北大核心 2004年第23期2144-2147,共4页 Journal of the Fourth Military Medical University
关键词 发酵 干扰素 大肠杆菌 fermentation IFN Escherichia.coli
  • 相关文献

参考文献10

  • 1Eric J, Frank GH. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities [J]. Oncology, 2001; 6: 34-55.
  • 2Pfeffer LM, Dinarello CA, Herberman RB, et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons [J]. Cancer Res, 1998; 58: 2489-2499.
  • 3Wadih A, Renata P, Erkki R. Cancer treatment by targeted drug delivery to tumor vasculature in mouse model[J]. Science, 1998; 279(16): 377-380.
  • 4孟洁如,颜真,赵宁,李波,张英起.导向性人干扰素α2a工程菌生物学特性的稳定性[J].中国生物制品学杂志,2003,16(4):222-224. 被引量:9
  • 5Makides SC. Strategies for the achieving high-level expression of genes in Escherichia coli[J]. Microbiol Rev, 1996; 60(3): 512-538.
  • 6Khalilzadeh R, Shojaosadati SA, Bahrami A, et al. Over-expression of recombinant human interferon-gamma in high cell density fermentation of Escherichia coli[J]. Biotechnol Lett, 2003;25(23):1989-1992.
  • 7Tabandeh F, Shojaosadati SA, Zomorodipour A, et al. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli[J]. Biotechnol Lett, 2004;26(3):245-250.
  • 8Srinivasan S, Barnard GC, Gerngross TU. Production of recombinant proteins using multiple-copy gene integration in high-cell-density fermentations of Ralstonia eutropha[J]. Biotechnol Bioeng, 2003;84(1):114-120.
  • 9Baheri HR, Roesler WJ, Hill GA. Modeling of recombinant bacteria fermentation for enhanced productivity[J]. Biotechnol Techniq, 1997; 17(2): 243-251.
  • 10Panda AK. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli[J]. Adv Biochem Eng Biotechnol, 2003;85:43-93.

二级参考文献3

共引文献8

同被引文献119

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部